Major Players in Drug Eluting Stents Market Focus on R&D of New Generation of Everolimu... - 0 views
-
ajinkyak on 17 Jul 21High prevalence of cardiovascular diseases is expected to propel growth of the global drug eluting stents market. According to the American Heart Association's Heart and Stroke Statistics 2019 Update, around 48% of all adults in the U.S. suffered from some type of cardiovascular disease in 2016.